Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action.
about
Artemisinin Action and Resistance in Plasmodium falciparumMefloquine and psychotomimetics share neurotransmitter receptor and transporter interactions in vitroElimination of Schistosoma mansoni in infected mice by slow release of artemisone.Efficient and stereocontrolled synthesis of 1,2,4-trioxolanes useful for ferrous iron-dependent drug delivery.Drug delivery to the malaria parasite using an arterolane-like scaffold.Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination.Trioxolane-Mediated Delivery of Mefloquine Limits Brain Exposure in a Mouse Model of Malaria.Monoclonal Antibodies That Recognize the Alkylation Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel).Haemoglobin degradation underpins the sensitivity of early ring stage Plasmodium falciparum to artemisininsImprovement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model.Ferrous iron-dependent drug delivery enables controlled and selective release of therapeutic agents in vivoRapid kill of malaria parasites by artemisinin and semi-synthetic endoperoxides involves ROS-dependent depolarization of the membrane potentialMethylene Homologues of Artemisone: An Unexpected Structure-Activity Relationship and a Possible Implication for the Design of C10-Substituted Artemisinins.Preliminary Evaluation of Artemisinin-Cholesterol Conjugates as Potential Drugs for the Treatment of Intractable Forms of Malaria and Tuberculosis.Parasite-Mediated Degradation of Synthetic Ozonide Antimalarials Impacts In Vitro Antimalarial Activity.Artemisone and Artemiside Are Potent Panreactive Antimalarial Agents That Also Synergize Redox Imbalance in Plasmodium falciparum Transmissible Gametocyte Stages
P2860
Q28276294-532AE0F6-1083-4818-8D4F-617D058AC30CQ28307141-A55BC136-2772-4EF5-91C4-B67B2038D659Q33681103-2224AFA0-A69C-4C61-8686-FAEA792EB7CCQ34488537-23D4EA65-6C69-42FE-9896-17C52A896171Q35570544-639C42DA-D037-4C8C-A9F1-6B49BD82EB76Q35666885-157D2C4E-25E9-426A-B876-CEB594B3B663Q36281039-F539B4BA-BEC9-4A51-AF2C-EBFEE724EB8DQ36478925-49D58E9D-7171-4B2B-9C2C-0705F14EA2A8Q36518570-F92B1656-E8A5-4F7B-B2BF-70E2CEAE620AQ37152937-0978903F-A050-435E-AE19-B93BADBF4E76Q37318264-40D61D2A-FB3A-4530-8100-04AB2DCEB4AAQ38294829-0FE6DB55-6902-4081-BDC7-C6EBB3446652Q39702161-FFB24538-0F20-46B1-939E-EF6B58A9AF48Q48018169-AF0A469F-0C2B-41E0-8C9C-5B6379FC5C33Q51771415-B19DE855-19B5-4062-A4D7-96245FAD1CE0Q56355670-4C955EF4-E875-4E57-960C-BE1C6789B0DB
P2860
Interactions between artemisinins and other antimalarial drugs in relation to the cofactor model--a unifying proposal for drug action.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Interactions between artemisin ...... ying proposal for drug action.
@en
type
label
Interactions between artemisin ...... ying proposal for drug action.
@en
prefLabel
Interactions between artemisin ...... ying proposal for drug action.
@en
P2093
P2860
P356
P1433
P1476
Interactions between artemisin ...... ying proposal for drug action.
@en
P2093
Amanda B Witte
Diego Monti
Ho-Ning Wong
Ho-Wai Chan
Kumar Sinniah
Kwan-Wing Cheu
Maggie Mei-Ki Tang
Min-Jiao Chen
Paolo Coghi
P2860
P304
P356
10.1002/CMDC.201200383
P577
2012-10-30T00:00:00Z